[
    [
        {
            "time": "",
            "original_text": "微评丨医疗影响力排行榜：复星医药、贵州百灵、万东医疗",
            "features": {
                "keywords": [
                    "医疗",
                    "影响力",
                    "排行榜",
                    "复星医药",
                    "贵州百灵",
                    "万东医疗"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "微评丨医疗影响力排行榜：复星医药、贵州百灵、万东医疗",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "带量采购引发医药股“雪崩” 2019年行业板块将如何演绎",
            "features": {
                "keywords": [
                    "带量采购",
                    "医药股",
                    "雪崩",
                    "2019年",
                    "行业板块"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "带量采购引发医药股“雪崩” 2019年行业板块将如何演绎",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "医药板块的“至暗时刻”！“4+7”带量采购降价幅度远超市场预期！恒瑞医药蒸发百亿",
            "features": {
                "keywords": [
                    "医药板块",
                    "至暗时刻",
                    "4+7",
                    "带量采购",
                    "降价",
                    "市场预期",
                    "恒瑞医药"
                ],
                "sentiment_score": -0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药板块的“至暗时刻”！“4+7”带量采购降价幅度远超市场预期！恒瑞医药蒸发百亿",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 10,
                "Impact": 10,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        }
    ]
]